Drug Database
Back to search

Poland· PL-100110100

Tolperis VP

A tolperisone product containing tolperisoni hydrochloridum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 7 of our 19 countries.

ATC M03BX04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTolperis VPATCM03BX04REGISTER NO.PL-100110100PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tolperisoni hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tolperisone is registered in 7 of 19 countries.

Countries holding a registration under ATC M03BX04 (tolperisone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search tolperisone products by name

Tolperisone · ATC M03BX04

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Germany
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tolperisone costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tolperisone · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Tolperisoni hydrochloridum
Manufacturer
Bausch Health Ireland Ltd.
Country
Poland (PL)
ATC code
M03BX04
ATC class
Tolperisone
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990959716
  • gtin
    05909990959723

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for tolperisone.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tolperisone against other medicinesHow interaction checks work

Tolperisone · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Tolperisone in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tolperisone products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Мидокалм, Толкимадо
  • Cyprus · Mydoflex
  • Czechia · Mydocalm
  • Germany · Mydocalm, Tolperison-Hcl Dura
  • Hungary · Flexirizon, Meditolp
  • Lithuania · Mydocalm
  • Latvia · Mydocalm
  • Netherlands · Tolpermyo
  • Romania · Myderison, Mydocalm
  • Slovakia · Mydocalm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aded7e67-d629-4455-8a65-be24c409a966
GET /v1/drugs/aded7e67-d629-4455-8a65-be24c409a966?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909990959716 ¦ Rp ¦ 19663\n30 tabl.\n05909990959723 ¦ Rp ¦ 19664\n90 tabl.",
  "substance": "Tolperisoni hydrochloridum 50 mg",
  "common_name": "Tolperisoni hydrochloridum",
  "pl_product_id": "100110100",
  "pozwolenie_nr": "09597",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about tolperisone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console